Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Inga Nehlmeier

6PUBLICATIONS

12CO-AUTHORS

Infectious agentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Speciation and extinctionCarbon capture engineering (excl. sequestration)Agricultural molecular engineering of nucleic acids and proteins

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 13, 2023

Omicron subvariant BA.5 efficiently infects lung cells.

Markus Hoffmann, Lok-Yin Roy Wong, Prerna Arora

|May 08, 2023

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage.

Inga Nehlmeier, Amy Kempf, Prerna Arora

|Mar 03, 2023

Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5.

Markus Hoffmann, Prerna Arora, Inga Nehlmeier

|May 17, 2022

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2.

Prerna Arora, Amy Kempf, Inga Nehlmeier

|Jan 05, 2022

No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2.

Prerna Arora, Amy Kempf, Inga Nehlmeier

|Oct 26, 2021

The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency.

Prerna Arora, Cheila Rocha, Amy Kempf

Pageof 1

Frequent Collaborators

6 joint publications

Stefan Pöhlmann

6 joint publications

Markus Hoffmann

5 joint publications

Sebastian Schulz

4 joint publications

Georg M N Behrens

3 joint publications

Hans-Martin Jäck

2 joint publications

Alexandra Dopfer-Jablonka

1 joint publications

Nico Joel Halwe

1 joint publications

Lorenz Ulrich

1 joint publications

Donata Hoffmann

1 joint publications

Martin Beer

Frequent Collaborators

6 joint publications

Stefan Pöhlmann

6 joint publications

Markus Hoffmann

5 joint publications

Sebastian Schulz

4 joint publications

Georg M N Behrens

Top Related Videos

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Published on : Sep 22, 2023

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on : Nov 21, 2023

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos

Top Related Videos

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Published on : Sep 22, 2023

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on : Nov 21, 2023

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos